Misonix Announces CE Mark Approval for Nexus

Misonix公司医疗设备Nexus获CE标志批准,推进产品扩大市场份额

2019-08-14 09:30:56 Investing News Network

本文共612个字,阅读需2分钟

Misonix has announced it has received CE Mark approval for its Nexus medical device. As quoted in the press release: The CE marking confirms that Nexus meets the requirements of the European Medical Devices Directive, which now allows Misonix to commercialize Nexus and its disposable products across the European Union and other CE Mark … Continued Misonix (NASDAQ:MSON) has announced it has received CE Mark approval for its Nexus medical device. As quoted in the press release: The CE marking confirms that Nexus meets the requirements of the European Medical Devices Directive, which now allows Misonix to commercialize Nexus and its disposable products across the European Union and other CE Mark geographies. Stavros Vizirgianakis, President and Chief Executive Officer of Misonix stated, “We are very pleased to report CE Mark approval for Nexus, as we continue to expand our footprint and diversify our revenue across markets and procedures. “Nexus marks an important leap forward for our Company, as we are bringing to market a powerful and highly integrated, easy-to-use system that we are confident will benefit both healthcare providers and patients by incorporating the latest advances in ultrasonic technology for increased efficiency and efficacy. Given the important benefits Nexus brings to both physicians and patients, we are confident that our ability to enter the European market will help deliver improved outcomes for treatments across spine surgery, neurosurgery, orthopedic surgery, cosmetic surgery, laparoscopic surgery, and other surgical and medical applications. In addition, the CE certification is important to supporting continued long-term growth across our recurring consumables revenue stream and in equipment product sales.” Click here to read the full press release.
Misonix 宣布其 Nexus 医疗设备已获得 CE 标志的批准。正如新闻稿中引用的: CE 标志确认 Nexus 符合欧洲医疗器械指令的要求,该指令现在允许 Misonix 将 Nexus 及其一次性产品在整个欧盟和其他 CE 标志商业化……继续 Misonix ( NASDAQ : MSON )宣布其 Nexus 医疗设备已获得 CE 标志批准。 如新闻稿所述: CE 标志确认 Nexus 符合欧洲医疗器械指令的要求,该指令现在允许 Misonix 将 Nexus 及其一次性产品在欧盟和其他 CE 标志地区商业化。 Misonix 总裁兼首席执行官 Stavros Vizigianakis 表示:“我们非常高兴地报告 CE Mark 对 Nexus 的批准,因为我们将继续扩大我们的足迹,并使我们的收入多样化,跨越市场和程序。 “ Nexus 标志着我们公司向前迈出了重要的一步,因为我们正在推出一个强大的、高度集成的、易于使用的系统,我们相信,通过结合超声波技术的最新进展,提高效率和功效,这将使医疗保健提供者和患者受益。鉴于 Nexus 给医生和患者带来的重要好处,我们相信,我们进入欧洲市场的能力将有助于改善脊柱外科、神经外科、骨科、美容外科、腹腔镜手术以及其他外科和医疗应用的治疗效果。此外, CE 认证对于支持我们经常性耗材收入流和设备产品销售的持续长期增长非常重要。” 单击此处阅读完整的新闻稿。

以上中文文本为机器翻译,存在不同程度偏差和错误;偶尔因源网页结构局限,内容无法一次完整呈现。请理解并参考原站原文阅读。

阅读原文